Stimulant And Polysubstance Use Policy Academy Final Report Introduction The drug overdose epidemic continues to worsen and has evolved over time. Many states are experiencing a resurgence in use and harms related to stimulants—particularly illicit stimulants—such as cocaine and methamphetamine. Although opioids—mainly synthetic opioids such as illicitly manufactured fentanyls—are currently[Read More…]
Author: Kentucky Recovery News
KET panel applauded Kentucky’s 5% drop in overdose deaths in 2022, but cited new challenges and remaining difficulties
By Melissa Patrick | Kentucky Health News A panel of survivors, drug-recovery experts and providers lauded Kentucky’s 5 percent reduction in drug-overdose deaths between 2021 and 2022 on a Kentucky Educational Television program, “Disrupting Addiction: A KET Forum,” but said there is still more work to do. Host[Read More…]
Study: Half of all people likely get mental illness in their lifetime
By Sri Ravipati A man sits huddled on a chair with his hands in front of his face. Photo: Jonas Walzberg About half of the world’s population “can expect to develop” at least one type of mental disorder by the time they are 75 years old, according to a new study published in the[Read More…]
DEA ‘Open To Considering’ Special Registration Process for Telehealth Controlled Substance Prescribing
By Chris Larson | August 4, 2023 The Drug Enforcement Administration (DEA) has openly signaled a reversal in its stance towards a long-mandated special registration process that would allow telehealth prescribing of certain controlled substances. In a newly published meeting notice, the DEA says the voluminous and negative feedback on its proposed rule[Read More…]
Addiction Treatment Should Embrace A Public Health Mission
As addiction professionals created the modern treatment sector, harm reduction strategies were viewed with skepticism. The opioid epidemic has forced a re-evaluation of harm reduction’s place in the treatment toolbox. This article takes a further step by suggesting that treatment professionals should view themselves part of the public health world.[Read More…]
THIS WEEK: Kentucky Recovery News | Weekly Update
Treatment, Recovery & Prevention LOCAL NEWS Beckers Behavioral Health: Addiction Recovery Care’s unique approach to addiction treatment The Daily Independent: ARC echoes U.S. Drug Czar’s call WKRC-TV: Ohio, Kentucky, and Indiana among top 10 states with most drug overdose deaths PR Newswire: Addiction Recovery Care (ARC) Partners with Accelecom for[Read More…]
New study shows drug manufacturers actually increased opioid marketing after Kentucky’s Purdue pharma lawsuit
by Strategic Management Society Kentucky’s 2007 lawsuit against Purdue Pharma marked a major turn in the opioid crisis. It was the first time a member of the Sackler family, who owned Purdue, was deposed about the company’s role in the opioid epidemic. Because the judge unsealed the court documents, public[Read More…]
Opioid addiction starts at the ER, according to studies.
by Bocconi University Legitimate prescriptions of opioids as painkillers are a contributing factor in long-term addiction to these substances. This is what Sarah Eichmeyer of Bocconi’s Department of Economics and Jonathan Zhang of McMaster University in Canada found and described in two recent papers, “Pathways into Opioid Dependence: Evidence from[Read More…]
A wasted chance to fight addiction? Opioid settlement cash fills a local budget gap.
Over the past two years, as state attorneys general agreed to more than $50 billion in legal settlements with companies that made or sold opioids, they vowed the money would be spent on addiction treatment and prevention. They were determined to avoid the misdirection of the tobacco settlement of the[Read More…]
Why Opioid Settlements Worth Over $8 Billion Are at Risk of Falling Apart
A number of multibillion-dollar settlements that opioid manufacturers and distributors agreed to pay may not wind up in the hands of addiction victims and state governments. By Alexander Saeedy Aug. 1, 2023 | 3:47 pm ET A number of prescription opioid manufacturers, including OxyContin developer Purdue Pharma and generics maker Mallinckrodt,[Read More…]